Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Hoth Therapeutics ($HOTH) Advances to Phase 2a Trials with New Skin…
Atara Biotherapeutics (ATRA) Secures Strategic Investments to Advance T-cell Immunotherapy Innovations
SPAR Group to Go Private in $2.50 Per Share Buyout by…
BioCardia Inc (Nasdaq: BCDA) Achieves Significant FDA Clearance for Morph DNA…
XORTX Therapeutics Inc ($XRTX): Pioneering New Treatments for Kidney Disease with…
Finance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Avalon GloboCare (ALBT) surges post Launch of Innovative Male Incontinence Device
Reason why Inspirato Incorporated (ISPO) has high trading volume today
Clearmind Medicine Inc (CMND) briefly surges and here’s why
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Citius Pharmaceuticals Inc. (NASDAQ:CTXR)
Tag: Citius Pharmaceuticals Inc. (NASDAQ:CTXR)
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Receives Study May Proceed Letter from...
Kate Hudson
-
March 1, 2022
0
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Finalizes Patient Enrolment In Pivotal Phase...
Gavins Felicity
-
December 29, 2021
0
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Completes Patients Recruitment In Phase 3...
Kate Hudson
-
December 13, 2021
0
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) Reports Study Results Showing Effectiveness of Mino-Lok...
Ash K
-
December 21, 2020
0
Citius Pharmaceuticals (NASDAQ:CTXR) And Novellus Therapeutics Enter Exclusive Global Licensing Agreement...
Gavins Felicity
-
October 15, 2020
0
1
2
Page 1 of 2
Recent Post
Hoth Therapeutics ($HOTH) Advances to Phase 2a Trials with New Skin...
Ash K
-
September 5, 2024
0
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a pioneering biopharmaceutical firm, has received significant advancements for its innovative dermatological therapy, HT-001, aimed at treating...
Atara Biotherapeutics (ATRA) Secures Strategic Investments to Advance T-cell Immunotherapy Innovations
September 4, 2024
SPAR Group to Go Private in $2.50 Per Share Buyout by...
September 3, 2024
BioCardia Inc (Nasdaq: BCDA) Achieves Significant FDA Clearance for Morph DNA...
August 29, 2024
XORTX Therapeutics Inc ($XRTX): Pioneering New Treatments for Kidney Disease with...
August 29, 2024